Heikki V. Huikuri

机构：Oulu University Hospital, University of Oulu

发表论文 32 篇 · 总被引 16231 次 · h-index 18

代表论文

• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2019 · European Heart Journal · 被引 4930)
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes (2023 · European Heart Journal · 被引 1596)
• Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial (2019 · The Lancet Diabetes & Endocrinology · 被引 332)
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol (2021 · Journal of the American College of Cardiology · 被引 146)
• Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab (2022 · Circulation · 被引 126)
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2020 · Archive ouverte UNIGE (University of Geneva) · 被引 62)